The management of HIV-hodgkin lymphoma

Michele Spina, Marcus Hentrich, Umberto Tirelli

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Since 1996, the availability of combination antiretroviral therapy (cART) has led to improvements in immune status among HIV-infected persons, reducing AIDS-related morbidity and prolonging survival. However, despite the impact of cART on HIV-related mortality, malignancies remain an important cause of death in the current era. The use of cART was also associated with reduced incidence of the two major AIDS-associated malignancies - Kaposi's sarcoma (KS) and high-grade non-Hodgkin lymphoma (NHL). However, among non-AIDS-defining cancers, an increased risk of Hodgkin lymphoma (HL), anal cancer, lung cancer, and liver cancer has been observed.

Original languageEnglish
Title of host publicationHodgkin Lymphoma: A Comprehensive Overview, Second Edition
PublisherSpringer International Publishing
Pages307-318
Number of pages12
ISBN (Print)9783319125053, 9783319125046
DOIs
Publication statusPublished - Jan 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The management of HIV-hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this